These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9413846)

  • 1. N-methyl-norsalsolinol, an endogenous neurotoxin, inhibits tyrosine hydroxylase activity in the rat brain nucleus accumbens in vitro.
    Scholz J; Bamberg H; Moser A
    Neurochem Int; 1997 Dec; 31(6):845-9. PubMed ID: 9413846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease.
    Moser A; Scholz J; Nobbe F; Vieregge P; Böhme V; Bamberg H
    J Neurol Sci; 1995 Aug; 131(2):183-9. PubMed ID: 7595645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotational behaviour and neurochemical changes in unilateral N-methyl-norsalsolinol and 6-hydroxydopamine lesioned rats.
    Moser A; Siebecker F; Nobbe F; Böhme V
    Exp Brain Res; 1996 Nov; 112(1):89-95. PubMed ID: 8951410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of N-methyl-norsalsolinol on monoamine oxidase of the rat caudate nucleus in vitro.
    Moser A; Scholz J; Bamberg H; Böhme V
    Neurochem Int; 1996 Jan; 28(1):109-12. PubMed ID: 8746770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines.
    Scholz J; Toska K; Luborzewski A; Maass A; Schünemann V; Haavik J; Moser A
    FEBS J; 2008 May; 275(9):2109-21. PubMed ID: 18355318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
    Nagatsu T; Hirata Y
    Eur Neurol; 1987; 26 Suppl 1():11-5. PubMed ID: 2884110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSF.
    Moser A; Kömpf D
    Life Sci; 1992; 50(24):1885-91. PubMed ID: 1598074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood-brain barrier in vivo.
    Thümen A; Behnecke A; Qadri F; Bäuml E; Thümen A; Behnecke CA; Qadri F; Bäuml E; Moser A
    Neuroreport; 2002 Jan; 13(1):25-8. PubMed ID: 11924888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) and related derivatives: chemistry and biochemical effects on catecholamine biosynthesis.
    Bringmann G; Feineis D; God R; Peters K; Peters EM; Scholz J; Riederer F; Moser A
    Bioorg Med Chem; 2002 Jul; 10(7):2207-14. PubMed ID: 11983518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tyrosine hydroxylase by R and S enantiomers of salsolinol, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline.
    Minami M; Takahashi T; Maruyama W; Takahashi A; Dostert P; Nagatsu T; Naoi M
    J Neurochem; 1992 Jun; 58(6):2097-101. PubMed ID: 1349343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxins: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1,2,3,4-tetrahydroisoquinoline and 1-methyl-6,7-dihydroxy-tetrahydroisoquinoline as substrates for FAD-containing monooxygenase of porcine liver microsomes.
    Wu RF; Miura S; Ichikawa Y
    Biochem Pharmacol; 1992 Nov; 44(10):2079-81. PubMed ID: 1449525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated cocaine injections have no influence on tyrosine hydroxylase activity in the rat nucleus accumbens core or shell.
    Licata SC; Pierce RC
    Brain Res; 2004 Jun; 1012(1-2):119-26. PubMed ID: 15158168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.
    Antkiewicz-Michaluk L; Romañska I; Papla I; Michaluk J; Bakalarz M; Vetulani J; Krygowska-Wajs A; Szczudlik A
    Neuroscience; 2000; 96(1):59-64. PubMed ID: 10683410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
    Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines.
    Maruyama W; Takahashi T; Minami M; Takahashi A; Dostert P; Nagatsu T; Naoi M
    Adv Neurol; 1993; 60():224-30. PubMed ID: 8093579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine-hydroxylase immunoreactive cells in the rat striatum following treatment with MPP+.
    O'Byrne MB; Bolam JP; Hanley JJ; Tipton KF
    Adv Exp Med Biol; 2000; 483():369-74. PubMed ID: 11787621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M; Dostert P; Yoshida M; Nagatsu T
    Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The search for endogenous or exogenous MPTP-like substances].
    Nagatsu T
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1497-500. PubMed ID: 2517047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
    Biochem Pharmacol; 1995 Nov; 50(11):1903-11. PubMed ID: 8615871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
    Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
    Brain Res Bull; 2001 Sep; 56(1):55-60. PubMed ID: 11604249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.